心力衰竭中的可溶性CD146:病理生理学作用和诊断潜力
Daniela Mocan1,2,3,4, Radu Jipa5,6, Daniel Alexandru Jipa7,8
1Multidisciplinary Doctoral School, Vasile Goldis Western University of Arad, 310025 Arad, Romania.
Biomedicines
|June 26, 2025
概括
溶性CD146 (sCD146) 显示为心力衰竭 (HF) 的生物标志物,反映了拥堵和内皮压力. 然而,其临床使用需要标准化,因为其可变性和非心脏影响.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 血管生物学 血管生物学
背景情况:
- 心力衰竭 (HF) 是一种具有全身影响的复杂疾病.
- 目前的生物标志物,如尿酸,不能完全代表高血压的血管功能障碍.
- CD146 (MCAM) 是一个参与血管过程的内皮细胞糖蛋白.
研究的目的:
- 审查CD146.6的结构,调节和释放.
- 探索可溶性CD146 (sCD146) 作为HF中的生物标记物的临床实用性.
- 评估sCD146在反映血液动力学拥堵和内皮压力的潜力.
主要方法:
- 文献综述综合了CD146和sCD146.6的当前知识.
- 对将sCD146水平与高频率指标和结果相关联的研究进行分析.
- 在病理生理刺激下评估sCD146的释放机制.
主要成果:
- 升高的sCD146水平与高频的拥堵指标 (心声学,放射学) 相相关.
- sCD146已与HF患者的不良结果有关.
- sCD146的释放是由内皮伸展,氧化应激和炎症刺激的.
结论:
- sCD146是高血压的一个有前途的生物标志物,反映了拥堵和内皮压力.
- 临床应用受到变异性,缺乏标准化以及恶性瘤等混因素的阻碍.
- 需要进一步的研究来标准化sCD146测量,并澄清其在HF中的作用.
相关概念视频
Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
223
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
223
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
71
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
71
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
353
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353


